Is there any vaccine for dengue?
Dengue Vaccine Globally A vaccine to prevent dengue (Dengvaxia®) is licensed and available in some countries for people aged 9 to 45 years. The World Health Organization recommends that the vaccine only be given to persons with confirmed previous dengue virus infection.
How much does dengue vaccine cost?
Treatment and vaccination costs A vaccine price per dose of $20 and pre-vaccination screening cost of $10 were applied from a study by Zeng et al., which focused on the cost-effectiveness of dengue vaccination in 10 endemic countries, including Indonesia [11].
What is the current status of dengue vaccine development?
Currently, Dengvaxia® is licensed in 20 countries. In large-scale clinical trials in Asia and Latin America, spanning over 25 months, the vaccine has been shown to prevent 93% of severe dengue cases and reduce dengue-related hospitalisations by 80%.
Is the dengue vaccine safe?
Evidence indicates that CYD-TDV is partially effective in preventing infection, but may lead to a higher risk of severe disease in those who have not been previously infected and then do go on to contract the disease. It is not clear why the vaccinated seronegative population have more serious adverse outcomes.
Who invented dengue vaccine?
A vaccine to prevent dengue fever discovered by a Saint Louis University researcher in 1997 and now licensed worldwide by Sanofi Pasteur has been approved for use in Mexico.
Can you vaccinate against dengue fever?
Preventing dengue There’s currently no widely available vaccine for dengue. You can prevent it by avoiding being bitten by mosquitoes.
Is dengue is a virus?
Dengue is a mosquito-borne viral infection, found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas. The virus responsible for causing dengue, is called dengue virus (DENV). There are four DENV serotypes, meaning that it is possible to be infected four times.
What country is Sanofi Pasteur from?
French
Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi….Sanofi Pasteur.
| Type | Division |
|---|---|
| Founded | August 2004 by merger |
| Headquarters | 14 Espace Henry Vallée, Lyon , France |
| Key people | David Loew Executive Vice President, Vaccines |
| Revenue | €4.74 billion (2015) |